Lumida
/NAMS
⌘K
NewAmsterdam Pharma Company NV

NewAmsterdam Pharma Company NV

NAMS
$31.68USD+2.03%+0.63 today

MARKET CAP

3.7B

P/E (TTM)

FWD P/E

DAY RANGE

$31 – $32

52W RANGE

$21
$42
Insider Trades29 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 22, 2026SellNAMSLouise Frederika KooijChief Accounting Officer80,000$20.74$3.7B-24.94%+54.32%$1.7M+0.00%
May 26, 2026SellNAMSLouise Frederika KooijChief Accounting Officer130,000$22.88$3.7B-24.94%+54.32%$3.0M+0.00%
Mar 5, 2026SellNAMSJohannes Jacob Pieter KasteleinChief Scientific Officer300,000$30.30$3.7B-24.94%+54.32%$9.1M-12.68%
Mar 2, 2026SellNAMSMichael H. DavidsonChief Executive Officer443,707$33.25$3.7B-24.94%+54.32%$14.8M-51.77%
Feb 24, 2026SellNAMSMichael H. DavidsonChief Executive Officer306,293$34.53$3.7B-24.94%+54.32%$10.6M-5.33%
Feb 20, 2026SellNAMSJohannes Jacob Pieter KasteleinChief Scientific Officer45,481$35.31$3.7B-24.94%+54.32%$1.6M-24.82%
Jan 27, 2026SellNAMSLouise Frederika KooijChief Accounting Officer144,856$21.58$3.7B-24.94%+54.32%$3.1M+0.00%
Jan 23, 2026SellNAMSLouise Frederika KooijChief Accounting Officer145,144$22.09$3.7B-24.94%+54.32%$3.2M+0.00%
Jan 20, 2026SellNAMSMayur Ian SomaiyaChief Financial Officer200,000$20.93$3.7B-24.94%+54.32%$4.2M+0.00%10b5-1
Jan 5, 2026SellNAMSLouise Frederika KooijChief Accounting Officer2,647$33.25$3.7B-24.94%+54.32%$88.0K-3.86%
Jan 5, 2026SellNAMSMayur Ian SomaiyaChief Financial Officer5,118$33.25$3.7B-24.94%+54.32%$170.2K-3.35%
Jan 5, 2026SellNAMSJohannes Jacob Pieter KasteleinChief Scientific Officer6,000$33.25$3.7B-24.94%+54.32%$199.5K-3.09%
Dec 23, 2025SellNAMSLouise Frederika KooijChief Accounting Officer290,000$22.94$3.7B-24.94%+54.32%$6.7M+0.00%
Sep 9, 2025SellNAMSLouise Frederika KooijChief Accounting Officer300,000$17.91$3.7B-24.94%+54.32%$5.4M+0.00%
Sep 3, 2025SellNAMSLouise Frederika KooijChief Accounting Officer18,073$25.09$3.7B-24.94%+54.32%$453.5K-54.65%
Aug 25, 2025SellNAMSLouise Frederika KooijChief Accounting Officer8,269$24.86$3.7B-24.94%+54.32%$205.6K-35.54%
Aug 21, 2025SellNAMSJohannes Jacob Pieter KasteleinChief Scientific Officer100,000$24.72$3.7B-24.94%+54.32%$2.5M-27.35%
Jul 15, 2025SellNAMSDouglas F KlingChief Operating Officer197,224$16.08$3.7B-24.94%+54.32%$3.2M+0.00%10b5-1
Jun 16, 2025SellNAMSDouglas F KlingChief Operating Officer200,000$14.74$3.7B-24.94%+54.32%$2.9M+0.00%10b5-1
May 15, 2025BuyNAMSDouglas F KlingChief Operating Officer100,000$10.00$3.7B-24.94%+54.32%$1.0M+20.20%
Apr 15, 2025BuyNAMSDouglas F KlingChief Operating Officer100,000$10.00$3.7B-24.94%+54.32%$1.0M+16.81%
Mar 17, 2025BuyNAMSDouglas F KlingChief Operating Officer11,888$10.00$3.7B-24.94%+54.32%$118.9K+1.43%
Mar 4, 2025SellNAMSLouise Frederika KooijChief Accounting Officer150,000$20.37$3.7B-24.94%+54.32%$3.1M-81.93%
Jan 27, 2025BuyNAMSMayur Ian SomaiyaChief Financial Officer61,883$9.26$3.7B-24.94%+54.32%$573.0K+3.83%
Oct 1, 2024SellNAMSLouise Frederika KooijChief Accounting Officer45,000$15.72$3.7B-24.94%+54.32%$707.4K-21.12%
Sep 26, 2024BuyNAMSJuliette Berangere AudetChief Business Officer1,104$15.70$3.7B-24.94%+54.32%$17.3K
Aug 20, 2024BuyNAMSMichael H. DavidsonChief Executive Officer5,000$16.27$3.7B-24.94%+54.32%$81.3K+2.44%
Jun 20, 2024BuyNAMSMichael H. DavidsonChief Executive Officer5,000$17.26$3.7B-24.94%+54.32%$86.3K+2.50%
Mar 26, 2024SellNAMSJohannes Jacob Pieter KasteleinChief Scientific Officer201,673$21.57$3.7B-24.94%+54.32%$4.3M-14.80%